Arcus Biosciences Inc (NYSE:RCUS) Director Kathryn E. Falberg bought 30,000 shares of the firm’s stock in a transaction on Monday, March 19th. The stock was bought at an average cost of $15.00 per share, for a total transaction of $450,000.00. The purchase was disclosed in a legal filing with the SEC, which is available through this link.

Arcus Biosciences stock opened at $17.71 on Thursday. Arcus Biosciences Inc has a 1 year low of $16.09 and a 1 year high of $22.10.

COPYRIGHT VIOLATION WARNING: “Arcus Biosciences Inc (RCUS) Director Kathryn E. Falberg Buys 30,000 Shares” was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this news story can be viewed at

Receive News & Ratings for Arcus Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcus Biosciences and related companies with's FREE daily email newsletter.